RT @drahmetrasim: Kızım, sana diyom: 100 yıldır bilinen gribe karşı geliştirilen tek ilaç olan Tamiflu, sadece belirtilerin ½-1 gün azalma…
RT @drahmetrasim: Kızım, sana diyom: 100 yıldır bilinen gribe karşı geliştirilen tek ilaç olan Tamiflu, sadece belirtilerin ½-1 gün azalma…
RT @drahmetrasim: Kızım, sana diyom: 100 yıldır bilinen gribe karşı geliştirilen tek ilaç olan Tamiflu, sadece belirtilerin ½-1 gün azalma…
RT @drahmetrasim: Kızım, sana diyom: 100 yıldır bilinen gribe karşı geliştirilen tek ilaç olan Tamiflu, sadece belirtilerin ½-1 gün azalma…
RT @drahmetrasim: Kızım, sana diyom: 100 yıldır bilinen gribe karşı geliştirilen tek ilaç olan Tamiflu, sadece belirtilerin ½-1 gün azalma…
RT @drahmetrasim: Kızım, sana diyom: 100 yıldır bilinen gribe karşı geliştirilen tek ilaç olan Tamiflu, sadece belirtilerin ½-1 gün azalma…
Kızım, sana diyom: 100 yıldır bilinen gribe karşı geliştirilen tek ilaç olan Tamiflu, sadece belirtilerin ½-1 gün azalmasını sağlıyor. İlacın grip komplikasyonlarını azaltacağına, zatürree, hastaneye yatış ve ölümleri önleyeceğine dair yeterli delil yok".
Al ser consultado sobre la pandemia de gripe A, Eduardo López dice que el tamiflú "si se daba correctamente evitaba casos graves". https://t.co/L3Q0Tv0j1q Pero hasta donde sé eso no fue demostrado🤔 https://t.co/wB7YTPbR1m
@a_chtung Да, нет, думаю таких исследований то много. Можно открыть кокрейновский обзор из 100 исследований и отобрать из него все которые были с положительными эффектами. Авторы писали что большинство исследований низкого с высоким риском систематической
RT @Nat_anest: В общем прошлый тред мы закончили на мега огромном кокрейновском обзоре 107 исследований по озельтамивиру и занамивиру. Выво…
В общем прошлый тред мы закончили на мега огромном кокрейновском обзоре 107 исследований по озельтамивиру и занамивиру. Выводы по озельтамивиру были такими: * Сокращает продолжительность симптомов гриппа на 17 часов. * Не снижает риск попасть в больницу
@dimtgl163 @SAN__TLT Сомнительным таким эффектом: https://t.co/KXh0yaUYDc
@marcsdionne @lferreiramoita Sadly not from the meta analysis 'Oseltamivir and zanamivir have small, non‐specific effects on reducing the time to alleviation of influenza symptoms in adults' https://t.co/izFqdPPlkT
@LucasAl55084477 @mari_fonseca Na vdd foi sou um exemplo, mas vai lá: A alopatia tem uma lógica científica, as práticas complementares outra. Não pode querer comparar de igual para igual. Precisa levar em conta coisas como contexto, cultura, satisfação do
インフルエンザはワクチンもタミフルもあると言う人がいるがワクチンを接種している人は38.6%しかいない https://t.co/AUpiiE7cDl タミフルは効き目が7日→6.3日と弱い https://t.co/dvFmHxK4n8 WHOはタミフルを補助薬に分類している https://t.co/Lw8cV27wkz #新型コロナウイルス
RT @pasanto_de: @maerx @bernhardschenk @SHomburg Die Grippe kann man medikamentös gut behandeln? Außer Neuraminidase-Hemmer innerhalb der e…
@maerx @bernhardschenk @SHomburg Die Grippe kann man medikamentös gut behandeln? Außer Neuraminidase-Hemmer innerhalb der ersten 12-48 Stunden nach auftreten der ersten Symptome gibt es für die Grippe keine Behandlung. Die Wirksamkeit von Neuraminidase-Hem
@Josefer70649021 @leandroruschel A quem interessar : https://t.co/v5eN1bJlJV
@AK_Meier @Coen_sk @christoph_chiu @petersinap @Sweetie30051 @Karl_Lauterbach @c_drosten Eine Therapie mit Neuraminidase-Hemmer ist lediglich 12-48 nach auftreten Symptome möglich. Zudem ist die Wirksamkeit äußerst zweifelhaft, zumal es die hospitalisierun
@thew0rd15theb1r @SHomburg @Marcus05911286 Man muss sie sehr früh einnehmen, wenn man meist noch nicht von einer Influenza ausgeht und eine Wirkung auf schwere Symptome ist eher mau: https://t.co/Nr8fj8MOhK
@CT_Bergstrom Let's hope it's more effective than Oseltamivir (Tamiflu). Oseltamivir is a pretty lousy treatment for the flu https://t.co/3JZT5E913F
@Mudit_Agrwal Agree! but lets dig deeper. Can HCQ do what ARV does for PEP in HIV, probably no! Recent systematic review: (not-peer reviewed) https://t.co/PMbEi1HoDs Can evidence guide us through this alone? take a trip down other well-established therap
@nicschebrodskiy да в том то и дело что нет https://t.co/TqxoveuFMr
@almuharrmi الطبيب الذي استضافه جيفيرسون لديه ما يقول عن Tamiflu كما ترى هنا: https://t.co/VdL5U123VD https://t.co/6wnB06wpT7 https://t.co/JND4aIoWBw ومشكلته ليست مع فاعليته تجاه المرض فقط، بل تجاه ضرورته لايقاف انتشاره كوباء، كما تسوق له روش.
الطبيب الذي استضافه جيفيرسون لديه ما يقول عن Tamiflu كما ترى هنا: https://t.co/i75wszUV92 https://t.co/Cow3MwkiS4 https://t.co/bDq81zAZ9F ومشكلته ليست مع فاعليته تجاه المرض فقط، بل تجاه ضرورته لايقاف انتشاره كوباء، كما تسوق له روش. https://t.co/NsmwGIXNFj
@heliobeltrao Moço. Tamiflu não moço. https://t.co/W1Xo37x9Mk
@barttels2 @Jennife10651535 @RogueRad @chadinabhan @emilymicheleL Use is not normally recommended as benefits are small and adverse effects common. In very sick patients there are some studies showing around 30% relative mortality reduction eerily reminis
RT @Nat_anest: Чтоб вы понимали после 4-х летнего сражения с Рош авторы кокрейновского обзора смогли получить доступ к 107 исследованиям/от…
RT @ToshiAkima: Remdesivir is the new Tamiflu and we’ll be debating for years whether it makes a meaningful impact https://t.co/K5TdjRL95l
RT @ToshiAkima: Remdesivir is the new Tamiflu and we’ll be debating for years whether it makes a meaningful impact https://t.co/K5TdjRL95l…
RT @ToshiAkima: Remdesivir is the new Tamiflu and we’ll be debating for years whether it makes a meaningful impact https://t.co/K5TdjRL95l
Bien vu. Le #remdesivir sera-t-il le nouveau Tamiflu ? (Qui raccourcit les symptômes sans véritablement changer la donne...) Avec de gros enjeux financiers et du lobbying lourd autour des choix des Etats... #COVID19
RT @MedicusFR: Et je ne suis pas le seul à parler de nouveau Tamiflu visiblement. C'est vraiment pas une bonne nouvelle. https://t.co/RRM1…
RT @ToshiAkima: Remdesivir is the new Tamiflu and we’ll be debating for years whether it makes a meaningful impact https://t.co/K5TdjRL95l
RT @ToshiAkima: Remdesivir is the new Tamiflu and we’ll be debating for years whether it makes a meaningful impact https://t.co/K5TdjRL95l…
RT @ToshiAkima: Remdesivir is the new Tamiflu and we’ll be debating for years whether it makes a meaningful impact https://t.co/K5TdjRL95l
RT @ToshiAkima: Remdesivir is the new Tamiflu and we’ll be debating for years whether it makes a meaningful impact https://t.co/K5TdjRL95l…
RT @ToshiAkima: Remdesivir is the new Tamiflu and we’ll be debating for years whether it makes a meaningful impact https://t.co/K5TdjRL95l…
RT @ToshiAkima: Remdesivir is the new Tamiflu and we’ll be debating for years whether it makes a meaningful impact https://t.co/K5TdjRL95l…
RT @ToshiAkima: Remdesivir is the new Tamiflu and we’ll be debating for years whether it makes a meaningful impact https://t.co/K5TdjRL95l
RT @ToshiAkima: Remdesivir is the new Tamiflu and we’ll be debating for years whether it makes a meaningful impact https://t.co/K5TdjRL95l
@fluidloading @SagittariusHH @MedicusFR Oseltamavir / influenza - Antiviraux / SARS-CoV-2 : même combat...
RT @ToshiAkima: Remdesivir is the new Tamiflu and we’ll be debating for years whether it makes a meaningful impact https://t.co/K5TdjRL95l…
RT @ToshiAkima: Remdesivir is the new Tamiflu and we’ll be debating for years whether it makes a meaningful impact https://t.co/K5TdjRL95l…
RT @ToshiAkima: Remdesivir is the new Tamiflu and we’ll be debating for years whether it makes a meaningful impact https://t.co/K5TdjRL95l…
Remdesivir is the new Tamiflu and we’ll be debating for years whether it makes a meaningful impact https://t.co/K5TdjRL95l
But if you like to really know the dark side of stories, I would suggest the video posted on https://t.co/rEwkJYY79y Hey. Watch it. It's worth. There's also a 2014 Cochrane metanalysis (https://t.co/aCztqJNeNh) reinforcing the very doubtful role of neuram
The influenza virus-specific mechanism of action proposed by the producers does not fit the clinical evidence.
Their paper was used to discredit the use of Tamiflu in prevention and early treatment of the Flu. Look under the Author Info. https://t.co/3YxWtxn6F4
@Charlotte3003G "Clinical study reports are unpublished, extensive documents with great detail on the trials that formed the basis for market approval. ... Clinical study reports have until now been confidential, seen only by the manufacturers and regulato
For those who want to know more... There's this article from @AnnalsofIM (2012): https://t.co/IpqywUOk4S The @cochranecollab review form 2014 https://t.co/PhKHq7QQ8G Here's an easier CME blog read from @srrezaie and the REBEL EM team: https://t.co/Q
@kksheld Ummm... Don't get your statement... There's this article from @AnnalsofIM (2012): https://t.co/IpqywUOk4S The @cochranecollab review form 2014 https://t.co/AgyfWr3sOS Here's an easier CME blog read from @srrezaie and the REBEL EM team: https://
Oseltamivir reduced the time to first alleviation of symptoms by 16.8 hours from 7 to 6.3 days. There was no effect in asthmatic children Zanamivir reduced the time by 0.60 days. The effect in children was not significant Cochrane Library https://t.co/dv
@HandtevyMD @MikeDoughney Arguing that Tamiflu is “standard of care” is ironic, Dr Andtevy, since it’s not,🤣AND that drug was a case study in biased, poorly designed trials, hidden data, & poor regulatory review.Cochrane Reviews 2014: https://t.co/sKpF
@WorstAtRoutine Deine Aussage missrepräsentiert die komplexe Evidenzlage. Z.B. https://t.co/uE26G8nRqd
@anthony_gossage @AndrewNoymer @V2019N Incorrect. By this logic we would be guided by the evidence on tamiflu. (See below) Confidence & good intentions aren't evidence. https://t.co/zNKlB7z0kN
@matthewherper @dsobek @adamfeuerstein @bradloncar Yes, that would be great. Can someone point to meaningful mortality data for any other antiviral intervention in an acute respiratory infection? Look at the Cochrane Tamiflu review. Unclear if there is any
発症前の症状出現予防には一定の効果が認められているようだけどね…。 今後もインフルが例年抑えられるといいねぇ、シンプルにみんなが衛生に気をつけただけでここまで抑えられるとわかったわけだし! https://t.co/Wr1iWovuPr
RT @docdu16: Voici les dernières données sur la grippe saisonnière et les neuraminidases. Pas fameux. https://t.co/g5zX02vH7A
RT @docdu16: Voici les dernières données sur la grippe saisonnière et les neuraminidases. Pas fameux. https://t.co/g5zX02vH7A https://t.co/…
RT @docdu16: Voici les dernières données sur la grippe saisonnière et les neuraminidases. Pas fameux. https://t.co/g5zX02vH7A
Voici les dernières données sur la grippe saisonnière et les neuraminidases. Pas fameux. https://t.co/g5zX02vH7A
@Dr_jaune Prescrire : Oséltamivir : rétention manifeste d’information, AMM injustifiable Prescrire : Oséltamivir : plus de 15 ans de rétention des données et d'enfumage systématique https://t.co/zwbsIjbhn3 https://t.co/fLU2aYNM8R
RT @LAURENCEJAMS: @BrandyZadrozny Here's five peer reviewed papers showing Tamiflu is useless and sometimes even dangerous. https://t.co/…
RT @LAURENCEJAMS: @BrandyZadrozny Here's five peer reviewed papers showing Tamiflu is useless and sometimes even dangerous. https://t.co/…
RT @LAURENCEJAMS: @BrandyZadrozny Here's five peer reviewed papers showing Tamiflu is useless and sometimes even dangerous. https://t.co/…
RT @LAURENCEJAMS: @BrandyZadrozny Here's five peer reviewed papers showing Tamiflu is useless and sometimes even dangerous. https://t.co/…
RT @LAURENCEJAMS: @BrandyZadrozny Here's five peer reviewed papers showing Tamiflu is useless and sometimes even dangerous. https://t.co/…
RT @LAURENCEJAMS: @BrandyZadrozny Here's five peer reviewed papers showing Tamiflu is useless and sometimes even dangerous. https://t.co/…
(27) https://t.co/Rljav1K61P Statements made on the capacity of oseltamivir to interrupt viral transmission and reduce complications are not supported by any data we have been able to access.
RT @King_Kozi: @DrPanMD @famfightflu @AmerAcadPeds 2014 Cochrane: one person was harmed for every 94 treated. https://t.co/0vlqgsygZg
RT @sarahhooleyhoo: @JackPosobiec @Cernovich Let’s do the “journalists” job for them... Here is SCIENCE on how Tamiflu is bullshit. https…
RT @cawebb0412: @jaimeraulmolina @Thesciencevort1 @DrJenGunter @JHowardBrainMD From the study you seem to keep posting, conclusions, “Using…
RT @sarahhooleyhoo: @JackPosobiec @Cernovich Let’s do the “journalists” job for them... Here is SCIENCE on how Tamiflu is bullshit. https…
RT @sarahhooleyhoo: @JackPosobiec @Cernovich Let’s do the “journalists” job for them... Here is SCIENCE on how Tamiflu is bullshit. https…
RT @LAURENCEJAMS: @BrandyZadrozny Here's five peer reviewed papers showing Tamiflu is useless and sometimes even dangerous. https://t.co/…
RT @sarahhooleyhoo: @JackPosobiec @Cernovich Let’s do the “journalists” job for them... Here is SCIENCE on how Tamiflu is bullshit. https…
@jordaniiix et vous lisez bien les arguments https://t.co/pJ2d1ml5Dy
RT @LAURENCEJAMS: @BrandyZadrozny Here's five peer reviewed papers showing Tamiflu is useless and sometimes even dangerous. https://t.co/…
RT @sarahhooleyhoo: @talialikeitis Who else has science on Tamiflu and reports of death, psychosis... please post so we can do these “journ…
RT @sarahhooleyhoo: @talialikeitis Who else has science on Tamiflu and reports of death, psychosis... please post so we can do these “journ…
RT @LAURENCEJAMS: @BrandyZadrozny Here's five peer reviewed papers showing Tamiflu is useless and sometimes even dangerous. https://t.co/…
RT @LAURENCEJAMS: @BrandyZadrozny Here's five peer reviewed papers showing Tamiflu is useless and sometimes even dangerous. https://t.co/…
RT @LAURENCEJAMS: @BrandyZadrozny Here's five peer reviewed papers showing Tamiflu is useless and sometimes even dangerous. https://t.co/…
RT @patrick_layton: "We found that both drugs shorten the duration of symptoms of influenza-like illness... by less than a day. [Tamiflu] d…
RT @patrick_layton: "We found that both drugs shorten the duration of symptoms of influenza-like illness... by less than a day. [Tamiflu] d…
Tamiflu shortens symptoms less than 1 day. Statistically insignificant. It has bad side effects, BEWARE!
RT @patrick_layton: "We found that both drugs shorten the duration of symptoms of influenza-like illness... by less than a day. [Tamiflu] d…